Fortem Financial Group, LLC Laboratory Corp Of America Holdings Transaction History

Fortem Financial Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	SELL	$203.72 - $248.97 $78,839 - $96,351	-387 Reduced 9.35%	3,754 $0
Q3 2022 Nov 01, 2022	SELL	$204.81 - $262.19 $50,383 - $64,498	-246 Reduced 5.61%	4,141 $848,000
Q2 2022 Jul 25, 2022	BUY	$213.86 - $277.87 $938,203 - $1.22 Million	4,387 New	4,387 $1.03 Million
Q1 2021 Apr 20, 2021	SELL	$204.88 - $255.03 $4,097 - $5,100	-20 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$186.91 - $214.42 $3,738 - $4,288	20 New	20 $4,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Fortem Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortem Financial Group, LLC with notifications on news.